Over the last 7 days, the Pharma industry has risen 2.4%, driven by gains from Eli Lilly of 2.3%. This takes the industry's 12 month performance to a gain of 18%. Earnings are forecast to grow by 28% annually.
Has the U.S. Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Tue, 11 Jun 2024 | US$1.9t | US$358.3b | US$14.1b | 15.6x | 136.5x | 5.4x |
Thu, 09 May 2024 | US$1.9t | US$358.2b | US$13.9b | 21x | 133.4x | 5.2x |
Sat, 06 Apr 2024 | US$1.9t | US$355.2b | US$22.7b | 24.7x | 82x | 5.2x |
Mon, 04 Mar 2024 | US$1.9t | US$355.3b | US$22.5b | 24.1x | 85x | 5.4x |
Wed, 31 Jan 2024 | US$1.8t | US$351.7b | US$24.9b | 28.7x | 71.3x | 5.1x |
Fri, 29 Dec 2023 | US$1.7t | US$375.2b | US$33.8b | 32.1x | 49.8x | 4.5x |
Sun, 26 Nov 2023 | US$1.7t | US$375.1b | US$33.9b | 26.2x | 48.8x | 4.4x |
Tue, 24 Oct 2023 | US$1.6t | US$382.7b | US$44.7b | 14.7x | 36.7x | 4.3x |
Thu, 21 Sep 2023 | US$1.7t | US$381.8b | US$43.9b | 18.3x | 39.1x | 4.5x |
Sat, 19 Aug 2023 | US$1.8t | US$381.6b | US$44.1b | 18.5x | 40.3x | 4.6x |
Mon, 17 Jul 2023 | US$1.7t | US$392.8b | US$60.2b | 18.3x | 27.7x | 4.2x |
Wed, 14 Jun 2023 | US$1.7t | US$392.8b | US$60.1b | 18.6x | 28.8x | 4.4x |
Fri, 12 May 2023 | US$1.7t | US$395.0b | US$57.5b | 20.3x | 30.3x | 4.4x |
Sun, 09 Apr 2023 | US$1.7t | US$401.2b | US$69.7b | 15.9x | 23.7x | 4.1x |
Tue, 07 Mar 2023 | US$1.6t | US$401.0b | US$69.4b | 17x | 22.7x | 3.9x |
Thu, 02 Feb 2023 | US$1.7t | US$403.0b | US$70.8b | 18x | 23.5x | 4.1x |
Sat, 31 Dec 2022 | US$1.8t | US$403.7b | US$70.7b | 16.8x | 24.8x | 4.3x |
Mon, 28 Nov 2022 | US$1.7t | US$403.7b | US$70.7b | 16.9x | 24.7x | 4.3x |
Wed, 26 Oct 2022 | US$1.7t | US$403.4b | US$72.1b | 13.5x | 22.9x | 4.1x |
Fri, 23 Sep 2022 | US$1.6t | US$403.0b | US$71.3b | 12.9x | 22x | 3.9x |
Sun, 21 Aug 2022 | US$1.7t | US$402.8b | US$70.1b | 15.3x | 23.7x | 4.1x |
Tue, 19 Jul 2022 | US$1.7t | US$392.4b | US$65.1b | 22x | 26.1x | 4.3x |
Thu, 16 Jun 2022 | US$1.6t | US$392.5b | US$64.7b | 20.6x | 24.3x | 4x |
Sat, 14 May 2022 | US$1.6t | US$392.5b | US$64.4b | 20.4x | 25.3x | 4.1x |
Mon, 11 Apr 2022 | US$1.7t | US$373.8b | US$60.7b | 22.4x | 28.5x | 4.6x |
Wed, 09 Mar 2022 | US$1.6t | US$373.6b | US$60.3b | 19.5x | 25.7x | 4.2x |
Fri, 04 Feb 2022 | US$1.6t | US$364.0b | US$40.7b | 21.6x | 39x | 4.4x |
Sun, 02 Jan 2022 | US$1.7t | US$361.1b | US$37.8b | 22.9x | 44x | 4.6x |
Tue, 30 Nov 2021 | US$1.5t | US$361.1b | US$38.1b | 22.6x | 40.6x | 4.3x |
Thu, 28 Oct 2021 | US$1.5t | US$341.0b | US$24.7b | 20.2x | 61.6x | 4.5x |
Sat, 25 Sep 2021 | US$1.5t | US$337.6b | US$25.8b | 22x | 58.3x | 4.5x |
Mon, 23 Aug 2021 | US$1.6t | US$338.5b | US$25.8b | 19.5x | 63x | 4.8x |
Sat, 10 Jul 2021 | US$1.5t | US$324.4b | US$20.4b | 23.4x | 73.2x | 4.6x |
73.2x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 0.84% | |
Healthcare | 1.84% | |
Pharma | 2.40% | |
Pharma | 2.40% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
LLY Eli Lilly | US$865.00 | 4.1% +US$30.4b | 94.2% | PE126.9x | |
MRK Merck | US$131.49 | 2.4% +US$7.8b | 19.7% | PE144.4x | |
ZTS Zoetis | US$178.83 | 3.7% +US$2.9b | 8.0% | PE34.1x | |
BMY Bristol-Myers Squibb | US$42.57 | 1.9% +US$1.6b | -34.3% | PS1.9x | |
CTLT Catalent | US$56.19 | 3.5% +US$345.7m | 31.3% | PS2.5x |